The present findings are also consistent with data from the randomized Interventional Study Evaluating the Short-Term Prediction of Preeclampsia/Eclampsia In Pregnant Women With Suspected Preeclampsia (INSPIRE) study, which examined the clinical utility of the sFlt-1/PlGF ratio using a cutoff of 38 (23). The gene discussed is PGF; the disease is preeclampsia.